Enanta Pharmaceuticals, Inc. ENTA
11.22 USD -0.25 (-2.18%)
At closeNov 10, 2026, 4:01 PM EST
11.22 0.00 0.00%
After hours · Nov 10, 4:01 PM ET
10.98 Day range 11.64
10.05 52-week range 17.15
- YTD
- -28.85%
- 1 year
- -2.52%
Revenue & Expenses
Latest period ending Sep 30, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 65.32M | 67.64M | 79.20M | 86.16M | 97.07M | |
| 65.32M | 67.64M | 79.20M | 86.16M | 97.07M | |
| -85.35M | -121.69M | -137.21M | -123.84M | -109.57M | |
| -81.89M | -116.05M | -133.82M | -121.75M | -79.00M | |
| -3.84 | -5.48 | -6.38 | -5.91 | -3.92 |
Balance sheet
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 32.30M | 37.84M | 85.39M | 47.96M | 57.81M | |
| 280.73M | 376.65M | 462.27M | 375.41M | 438.79M | |
| 216.01M | 247.84M | 245.54M | 54.08M | 39.36M | |
| 57.90M | 55.47M | 26.51M | 25.26M | 5.33M | |
| 64.72M | 128.81M | 216.74M | 321.33M | 399.43M |
Cash flow
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| -19.27M | -78.76M | -103.15M | -84.78M | -70.00M | |
| 40.35M | 58.23M | -53.58M | 54.90M | 36.99M | |
| -26.62M | -27.63M | 198.13M | 20.03M | 3.08M | |
| -12.90M | -17.95M | -9.06M | -2.13M | -750.00K | |
| -5.54M | -48.16M | 41.39M | -9.85M | -29.93M |